ArticleFrontiers in oncology2020

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.

Kristen P Zeligs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.